The impact of methylphenidate and its enantiomers on dopamine synthesis and metabolism in vitro

[1]  T. Nagatsu,et al.  Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson’s disease (PD): historical overview and future prospects , 2016, Journal of Neural Transmission.

[2]  Pengfei Li,et al.  MCPB.py: A Python Based Metal Center Parameter Builder , 2016, J. Chem. Inf. Model..

[3]  A. Straughn,et al.  Absorption Differences between Immediate-Release Dexmethylphenidate and dl-Methylphenidate , 2016, Drug Metabolism and Disposition.

[4]  N. Fernàndez-Castillo,et al.  Discovery of compounds that protect tyrosine hydroxylase activity through different mechanisms. , 2015, Biochimica et biophysica acta.

[5]  Berk Hess,et al.  GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers , 2015 .

[6]  C. Simmerling,et al.  ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.

[7]  D. Edmondson,et al.  Reversible and irreversible small molecule inhibitors of monoamine oxidase B (MAO-B) investigated by biophysical techniques. , 2015, Bioorganic & medicinal chemistry.

[8]  Massimiliano Bonomi,et al.  PLUMED 2: New feathers for an old bird , 2013, Comput. Phys. Commun..

[9]  L. Greenhill,et al.  Psychostimulants and Other Drugs Used in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) , 2014 .

[10]  M. M. Ferreira,et al.  The influence of R and S configurations of a series of amphetamine derivatives on quantitative structure-activity relationship models. , 2013, Analytica chimica acta.

[11]  Wim F Vranken,et al.  ACPYPE - AnteChamber PYthon Parser interfacE , 2012, BMC Research Notes.

[12]  N. Greig,et al.  Molecular docking study of catecholamines and [4-(propan-2-yl) phenyl]carbamic acid with tyrosine hydroxylase. , 2012, CNS & neurological disorders drug targets.

[13]  Gregory A Ross,et al.  Rapid and Accurate Prediction and Scoring of Water Molecules in Protein Binding Sites , 2012, PloS one.

[14]  M. F. Salvatore,et al.  Dichotomy of Tyrosine Hydroxylase and Dopamine Regulation between Somatodendritic and Terminal Field Areas of Nigrostriatal and Mesoaccumbens Pathways , 2012, PloS one.

[15]  Peter Riederer,et al.  Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways , 2012, Journal of Neural Transmission.

[16]  J. Brady,et al.  Molecular dynamics simulation studies of caffeine aggregation in aqueous solution. , 2011, The journal of physical chemistry. B.

[17]  P. Riederer,et al.  Effects of methylphenidate: the cellular point of view , 2010, Attention deficit and hyperactivity disorders.

[18]  B. Herpertz-Dahlmann,et al.  Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder. , 2010, Journal of child and adolescent psychopharmacology.

[19]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[20]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[21]  Mario A. González,et al.  Evolution of stimulants to treat ADHD: transdermal methylphenidate , 2009, Human psychopharmacology.

[22]  P. Dickson,et al.  Tyrosine hydroxylase activity is regulated by two distinct dopamine‐binding sites , 2008, Journal of neurochemistry.

[23]  J. Haavik,et al.  Tetrahydrobiopterin shows chaperone activity for tyrosine hydroxylase , 2008, Journal of neurochemistry.

[24]  J. Markowitz,et al.  Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? , 2008, Journal of clinical psychopharmacology.

[25]  D. Quinn.  Does Chirality Matter?: Pharmacodynamics of Enantiomers of Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder , 2008, Journal of clinical psychopharmacology.

[26]  T. Wilens.  Pharmacotherapy of ADHD in Adults , 2008, CNS Spectrums.

[27]  Berk Hess,et al.  P-LINCS:  A Parallel Linear Constraint Solver for Molecular Simulation. , 2008, Journal of chemical theory and computation.

[28]  F. Marshall,et al.  Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain , 2007, Neuropharmacology.

[29]  M. Parrinello,et al.  Canonical sampling through velocity rescaling. , 2007, The Journal of chemical physics.

[30]  N. Hayashi,et al.  Molecular mechanism for pterin-mediated inactivation of tyrosine hydroxylase: formation of insoluble aggregates of tyrosine hydroxylase. , 2006, Journal of biochemistry.

[31]  D. Heal,et al.  Methylphenidate and its Isomers , 2006, CNS drugs.

[32]  L. Sreerama,et al.  Aldehyde Dehydrogenases: Measurement of Activities and Protein Levels , 2005, Current protocols in toxicology.

[33]  R. Meier,et al.  Ritalin, eine neuartige synthetische Verbindung mit spezifischer zentralerregender Wirkungskomponente , 1954, Klinische Wochenschrift.

[34]  J. Kehr,et al.  Application of triple-probe microdialysis for fast pharmacokinetic/pharmacodynamic evaluation of dopamimetic activity of drug candidates in the rat brain , 2004, Journal of Neuroscience Methods.

[35]  J. Swanson,et al.  Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention- , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[36]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[37]  D. Murry,et al.  Methylphenidate Is Stereoselectively Hydrolyzed by Human Carboxylesterase CES1A1 , 2004, Journal of Pharmacology and Experimental Therapeutics.

[38]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[39]  T. Crow,et al.  Effect of chronic amphetamine administration on central dopaminergic mechanisms in the vervet , 2004, Psychopharmacology.

[40]  A. Straughn,et al.  Advances in the Pharmacotherapy of Attention‐Deficit‐Hyperactivity Disorder: Focus on Methylphenidate Formulations , 2003, Pharmacotherapy.

[41]  J. Swanson,et al.  Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications , 2002, Synapse.

[42]  F. Tarazi,et al.  Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning , 2002, Psychopharmacology.

[43]  S. Mandel,et al.  Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss. , 2001 .

[44]  T. Challman,et al.  Methylphenidate: its pharmacology and uses. , 2000, Mayo Clinic proceedings.

[45]  M. Milanese,et al.  Activation of monoamine oxidase type-B by aluminum in rat brain homogenate. , 1999, Neuroreport.

[46]  M F Sanner,et al.  Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.

[47]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[48]  R C Stevens,et al.  Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 A resolution: self-hydroxylation of Phe300 and the pterin-binding site. , 1998, Biochemistry.

[49]  N. Panchuk-Voloshina,et al.  A one-step fluorometric method for the continuous measurement of monoamine oxidase activity. , 1997, Analytical biochemistry.

[50]  Raymond C. Stevens,et al.  Crystal structure of tyrosine hydroxylase at 2.3 Å and its implications for inherited neurodegenerative diseases , 1997, Nature Structural Biology.

[51]  M. Sanner,et al.  Reduced surface: an efficient way to compute molecular surfaces. , 1996, Biopolymers.

[52]  James E. Smith,et al.  Chronic Cocaine Administration Increases CNS Tyrosine Hydroxylase Enzyme Activity and mRNA Levels and Tryptophan Hydroxylase Enzyme Activity Levels , 1993, Journal of neurochemistry.

[53]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[54]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[55]  G. Breese,et al.  Pharmacology of the enantiomers of threo-methylphenidate. , 1987, The Journal of pharmacology and experimental therapeutics.

[56]  Robinson Jb.  Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors: Enantiomers of amphetamine, n-methylamphetamine and deprenyl , 1985 .

[57]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[58]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[59]  C. Kilts,et al.  Synthesis and pharmacology of hydroxylated metabolites of methylphenidate. , 1981, Journal of medicinal chemistry.

[60]  A. Mandell,et al.  Striatal tyrosine hydroxylase activity: multiple conformational kinetic oscillators and product concentration frequencies , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[61]  N. Uretsky,et al.  The Relationship Between the Stimulation of Dopamine Synthesis and Release Produced by Amphetamine and High Potassium in Striatal Slices , 1980, Journal of neurochemistry.

[62]  J. Gibb,et al.  Effects of methamphetamine on kinetic characteristics of neostriatal tyrosine hydroxylase. , 1980, Life sciences.

[63]  T. Kato,et al.  Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. , 1979, Journal of chromatography.

[64]  M. M. Roberts,et al.  Amphetamine- and phenylethylamine-induced alterations in dopamine synthesis regulation in rat brain striatal synaptosomes. , 1979, The Journal of pharmacology and experimental therapeutics.

[65]  T. Kato,et al.  Effects of stereochemical structures of tetrahydrobiopterin on tyrosine hydroxylase. , 1977, Biochimica et biophysica acta.

[66]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[67]  R. Borchardt.  A rapid spectrophotometric assay for catechol-O-methyltransferase. , 1974, Analytical biochemistry.

[68]  S. Udenfriend,et al.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. , 1964, The Journal of biological chemistry.